Philadelphia Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Philadelphia Trust CO

$1.17 Billion
Q1 2025

A detailed history of Philadelphia Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 2,415 shares of REGN stock, worth $1.46 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,415

Previous 2,415 -0.0%

Holding current value

$1.46 Million

Previous $1.72 Million 10.93%

% of portfolio

0.13%

Previous 0.13%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.28 Million - $1.5 Million	1,250 Added 107.3%	2,415 $2.54 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $7,065 - $8,569	-8 Reduced 0.68%	1,165 $1.22 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $13,540 - $14,900	15 Added 1.3%	1,173 $1.13 Million
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $176,472 - $191,597	-250 Reduced 17.76%	1,158 $835,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $2.32 Million - $3.12 Million	-4,224 Reduced 75.0%	1,408 $832,000
Q1 2022 May 05, 2022	BUY	$595.12 - $698.43 $2.52 Million - $2.96 Million	4,232 Added 302.29%	5,632 $3.93 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $625,422 - $767,480	1,400 New	1,400 $662,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $220,079 - $265,916	-404 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $47,358 - $61,816	-96 Reduced 19.2%	404 $252,000
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $355,678 - $523,106	-1,058 Reduced 67.91%	500 $244,000
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $25,494 - $35,015	-93 Reduced 5.63%	1,558 $585,000
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $494,639 - $684,867	1,651 New	1,651 $517,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $218,283 - $261,976	-650 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $228,241 - $265,531	650 New	650 $263,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $6.86 Million - $8.99 Million	-19,136 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $8.25 Million - $9.64 Million	19,136	19,136 $8.56 Million

Others Institutions Holding REGN

# of Institutions

1,469

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Regeneron Pharmaceuticals, Inc. Transaction History